Sotac Pharmaceuticals Ltd

SOTAC

Watchlist

AI Mode

‌

Market Cap

₹ 136 Cr

P/E

17.76

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Sotac Pharmaceuticals Limited is a pharmaceutical manufacturing company in Gujarat, India, specializing in a wide range of pharmaceutical products under loan licensing or contract manufacturing partnerships.

The company has a robust portfolio covering therapeutic areas such as anti-diabetics, anti-psychotics, and antibiotics, serving a broad client base in pharmaceutical development and production.

In 2022, Sotac Pharmaceuticals expanded strategically by acquiring holdings in SOTAC Healthcare and SOTAC Research, indicating a significant shift towards enhancing its research and healthcare capabilities.

The company went public with an IPO in April 2023, raising Rs 33 crore, which will likely support its expansion and operational initiatives.

Sotac Pharmaceuticals has been on a growth trajectory since its establishment, now operating as a public limited company, reflecting increasing trust and ambition within the pharmaceutical sector.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

136 Cr

Volatility

Moderate Risk

P/E Ratio

17.8

Industry P/E

30.8

PEG Ratio

1.4

P/B Ratio

2.6

52W High

152.35

52W Low

88.05

Sales CAGR

-6.59%

-5.17%

16.81%

10Y

—

Profit CAGR

159.22%

13.13%

31.15%

10Y

—

ROE

TTM

15.37%

12.28%

14.75%

10Y

—

ROCE

TTM

16.39%

16.64%

19.16%

10Y

—

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ALPA	79.02	170 Cr	9.11	0.93	0.00	10.18	12.57	7.85
BALAXI	28.71	160 Cr	11.04	0.67	0.00	6.09	7.48	4.50
SOTAC	123.40	136 Cr	17.76	2.56	0.00	15.37	16.39	8.19
ACHYUT	5.68	132 Cr	280.00	4.21	0.00	1.36	1.73	1.26
BALPHARMA	71.50	119 Cr	17.40	1.52	1.61	8.71	8.78	1.97
DENISCHEM	79.30	109 Cr	15.17	1.24	1.92	8.16	14.50	5.79
VAISHALI	8.04	105 Cr	—	1.56	0.00	-0.57	1.54	-0.32

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	20	40	20	18	25	27	26	26	25
Expenses	18	36	18	16	23	25	23	25	23
Operating Profit	1.92	3.40	1.77	2.42	2.33	2.08	2.91	1.18	2.22
OPM %	9.66	8.55	9.01	13.38	9.33	7.80	11.31	4.46	8.79
Other Income	0.07	0.78	0.01	0.14	0.23	0.05	0.38	0.35	0.25
Interest	0.29	1.06	0.27	0.64	0.46	0.67	0.99	0.35	0.42
Depreciation	0.50	1.11	0.56	0.61	0.60	0.78	0.83	0.88	0.75
Profit Before Tax	1.19	2.01	0.95	1.31	1.50	0.69	1.47	0.30	1.30
Tax %	55.46	49.75	38.95	20.61	34.67	68.12	40.82	-403.33	-3.85
Net Profit	0.54	1.02	0.58	1.04	0.98	0.21	0.88	1.51	1.35
EPS in Rs	—	—	—	—	—	0.58	—	1.49	—

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	29	49	77	104	97	104
Expenses	27	47	70	95	83	96
Operating Profit	1.86	1.45	7.25	8.52	14	8.39
OPM %	6.51	2.98	9.36	8.20	14.06	8.06
Other Income	0.22	0.11	0.35	0.49	3.90	1.03
Interest	0.33	1.02	1.98	1.70	2.58	2.43
Depreciation	1.40	2.59	2.28	3.10	3.84	3.24
Profit Before Tax	0.36	-2.06	3.93	3.96	11	3.76
Tax %	75.49	-15.02	41.78	9.70	16.59	-5.05
Net Profit	0.09	-2.37	2.29	3.58	9.28	3.95
EPS in Rs	—	—	8.61	3.90	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025
Equity Capital	2.30	2.30	8.05	11	11
Reserves	0.76	0.19	11	34	42
Borrowings	13	17	22	25	44
Other Liabilities	14	15	32	35	27
Total Liabilities	30	35	74	105	124
Fixed Assets	16	17	26	36	49
CWIP	0.00	0.00	0.04	5.12	0.20
Investments	0.16	0.30	0.00	2.10	3.78
Other Assets	14	18	48	63	72
Total Assets	30	35	74	105	124

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.06	-0.31	8.14	-16	-4.33
Cash from Investing Activity	-12	-3.23	-12	-20	-14
Cash from Financing Activity	11	3.38	13	30	16
Net Cash Flow	-0.29	-0.16	9.61	-6.26	-1.85

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Apr 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025
Promoters	72.85%	72.85%	72.85%	72.85%	72.85%	72.85%
FIIs	12.88%	8.51%	8.99%	8.88%	15.12%	16.14%
DIIs	0.00%	-0.00%	0.00%	0.00%	0.68%	0.00%
Public	14.27%	18.64%	18.16%	18.27%	11.35%	11.01%
Total Shareholders	784	255	245	251	243	240

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jan 02, 2025	Sandhya singh gahlaut	Bulk	Sell	116.30	1.16 Cr	99,600	0.90
Feb 22, 2024	Nav capital vcc - nav capital...	Bulk	Buy	135.42	0.98 Cr	72,000	0.65
Feb 21, 2024	Nav capital vcc - nav capital...	Bulk	Buy	132.16	0.97 Cr	73,200	0.66
Feb 21, 2024	Sunflower broking private lim...	Bulk	Sell	132.18	0.94 Cr	70,800	0.64
Jan 12, 2024	Sandhyasingh anupamsingh gahlout	Bulk	Buy	116.59	1.23 Cr	1,05,600	0.95
Oct 09, 2023	Sambhavnath investments and f...	Bulk	Buy	120.99	1.12 Cr	92,400	0.83
Oct 09, 2023	Ag dynamic funds limited	Bulk	Sell	121.00	1.10 Cr	91,200	0.82
Sep 05, 2023	Nav capital vcc - nav capital...	Bulk	Sell	124.24	1.57 Cr	1,26,000	1.14
Jul 31, 2023	Sunflower broking private lim...	Bulk	Sell	117.42	1.25 Cr	1,06,800	0.96
Jul 31, 2023	V joshi impex private limited	Bulk	Buy	117.50	0.82 Cr	69,600	0.62

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Overview

Detailed Summary

The company has a robust portfolio covering therapeutic areas such as anti-diabetics, anti-psychotics, and antibiotics, serving a broad client base in pharmaceutical development and production.

The company went public with an IPO in April 2023, raising Rs 33 crore, which will likely support its expansion and operational initiatives.

Sotac Pharmaceuticals has been on a growth trajectory since its establishment, now operating as a public limited company, reflecting increasing trust and ambition within the pharmaceutical sector.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

136 Cr

Volatility

Moderate Risk

P/E Ratio

17.8

Industry P/E

30.8

PEG Ratio

1.4

P/B Ratio

2.6

52W High

152.35

52W Low

88.05

Sales CAGR

-6.59%

-5.17%

16.81%

10Y

—

Profit CAGR

159.22%

13.13%

31.15%

10Y

—

ROE

TTM

15.37%

12.28%

14.75%

10Y

—

ROCE

TTM

16.39%

16.64%

19.16%

10Y

—

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Sales	20	40	20	18	25	27	26	26	25
Expenses	18	36	18	16	23	25	23	25	23
Operating Profit	1.92	3.40	1.77	2.42	2.33	2.08	2.91	1.18	2.22
OPM %	9.66	8.55	9.01	13.38	9.33	7.80	11.31	4.46	8.79
Other Income	0.07	0.78	0.01	0.14	0.23	0.05	0.38	0.35	0.25
Interest	0.29	1.06	0.27	0.64	0.46	0.67	0.99	0.35	0.42
Depreciation	0.50	1.11	0.56	0.61	0.60	0.78	0.83	0.88	0.75
Profit Before Tax	1.19	2.01	0.95	1.31	1.50	0.69	1.47	0.30	1.30
Tax %	55.46	49.75	38.95	20.61	34.67	68.12	40.82	-403.33	-3.85
Net Profit	0.54	1.02	0.58	1.04	0.98	0.21	0.88	1.51	1.35
EPS in Rs	—	—	—	—	—	0.58	—	1.49	—

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	29	49	77	104	97	104
Expenses	27	47	70	95	83	96
Operating Profit	1.86	1.45	7.25	8.52	14	8.39
OPM %	6.51	2.98	9.36	8.20	14.06	8.06
Other Income	0.22	0.11	0.35	0.49	3.90	1.03
Interest	0.33	1.02	1.98	1.70	2.58	2.43
Depreciation	1.40	2.59	2.28	3.10	3.84	3.24
Profit Before Tax	0.36	-2.06	3.93	3.96	11	3.76
Tax %	75.49	-15.02	41.78	9.70	16.59	-5.05
Net Profit	0.09	-2.37	2.29	3.58	9.28	3.95
EPS in Rs	—	—	8.61	3.90	—	—
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025
Equity Capital	2.30	2.30	8.05	11	11
Reserves	0.76	0.19	11	34	42
Borrowings	13	17	22	25	44
Other Liabilities	14	15	32	35	27
Total Liabilities	30	35	74	105	124
Fixed Assets	16	17	26	36	49
CWIP	0.00	0.00	0.04	5.12	0.20
Investments	0.16	0.30	0.00	2.10	3.78
Other Assets	14	18	48	63	72
Total Assets	30	35	74	105	124

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2020	Mar 2021	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.06	-0.31	8.14	-16	-4.33
Cash from Investing Activity	-12	-3.23	-12	-20	-14
Cash from Financing Activity	11	3.38	13	30	16
Net Cash Flow	-0.29	-0.16	9.61	-6.26	-1.85

Oscillators

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ALPA	79.02	170 Cr	9.11	0.93	0.00	10.18	12.57	7.85
BALAXI	28.71	160 Cr	11.04	0.67	0.00	6.09	7.48	4.50
SOTAC	123.40	136 Cr	17.76	2.56	0.00	15.37	16.39	8.19
ACHYUT	5.68	132 Cr	280.00	4.21	0.00	1.36	1.73	1.26
BALPHARMA	71.50	119 Cr	17.40	1.52	1.61	8.71	8.78	1.97
DENISCHEM	79.30	109 Cr	15.17	1.24	1.92	8.16	14.50	5.79
VAISHALI	8.04	105 Cr	—	1.56	0.00	-0.57	1.54	-0.32